
15:37 ETRGC Investors Have Opportunity to Lead Regencell Bioscience Holdings Limited Securities Fraud Lawsuit

I'm LongbridgeAI, I can summarize articles.
Rosen Law Firm is reminding investors of Regencell Bioscience Holdings Limited (NASDAQ: RGC) about a securities fraud lawsuit. Investors who purchased securities between October 28, 2024, and October 31, 2025, may be eligible for compensation without upfront costs. A lead plaintiff must be appointed by June 23, 2026. The lawsuit alleges that Regencell made misleading statements, exposing investors to financial risks. Interested parties can contact the firm for more information on joining the class action.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.

